Varivax®

BIOLOGICAL6 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), GlaxoSmithKline, Merck Sharp & Dohme LLC, SK Bioscience Co., Ltd.

Conditions

Haemophilus Influenzae Type bHepatitis AKidney Transplant RecipientsMeaslesMeasles-Mumps-Rubella VaccineMumpsNeisseria MeningitidisRubella

Phase 1

Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients

TerminatedNCT00005009

National Institute of Allergy and Infectious Diseases (NIAID)Kidney Transplant Recipients

Start: 1998-02-28End: 2001-06-16Updated: 2017-02-16

Phase 2

Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines

CompletedNCT00134719

GlaxoSmithKlineHaemophilus Influenzae Type b, Neisseria Meningitidis

Start: 2005-04-11End: 2007-02-21Updated: 2018-07-19

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

CompletedNCT00861744

GlaxoSmithKlineMeasles, Measles-Mumps-Rubella Vaccine, Mumps +1

Start: 2009-06-03End: 2012-06-18Updated: 2020-01-03

Phase 3

Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children

CompletedNCT00197015

GlaxoSmithKlineHepatitis A

Start: 2003-10-06End: 2009-06-09Updated: 2018-07-31

SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years

Not yet recruitingNCT07415252

SK Bioscience Co., Ltd.Varicella (Chickenpox)

Start: 2026-06-05End: 2028-01-02Target: 780Updated: 2026-02-17

Phase 4

Safety Study of a Refrigerator-stable Formulation of VARIVAX®

CompletedNCT00432731

Merck Sharp & Dohme LLCMeasles, Mumps, Rubella +1

Start: 2004-12-31End: 2005-09-30Target: 500Updated: 2017-03-14

Related Papers

Two-year antibody persistence in children vaccinated at 12–15 months with a measles-mumps-rubella virus vaccine without human serum albumin

Human Vaccines & Immunotherapeutics2017-05-0811 citations

Safety and Immunogenicity of Human Serum Albumin-Free MMR Vaccine in US Children Aged 12-15 Months

Journal of the Pediatric Infectious Diseases Society2014-08-0720 citations

Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers: a pooled analysis of randomized trials.

2012-08-017 citations